Adrenergic Modulation of Hepatotoxicity

References

• Calvert D. N., Brody T. M. ldquo;Role of the sympathetic nervous system in CC 14 hepatotoxicity”. Am. J. Physiol. 1960; 198: 669–676
   PubMed Web of Science ®Google Scholar
• Brody T. M., Calvert D. N., Schneider A. F. Alteration of carbon tetrachloride-induced pathological changes in the rat by spinal transection, adrenalectomy and adrenergic blocking agents. J. Pharmacol. Exp. Ther. 1961; 131: 341–345
   Web of Science ®Google Scholar
• Larson R. E., Plaa G. L. Spinal cord transection and CCl4 toxicity. Experientia 1963; 19: 604–606
   PubMedGoogle Scholar
• Larson R. E., Plaa G. L. A correlation of the effects of cervical cordotomy, hypothermia, and catecholamines and carbon tetrachloride-induced hepatic necrosis. J. Pharmacol. Exp. Ther. 1965; 147: 103–111
   PubMed Web of Science ®Google Scholar
• Larson R. E., Plaa G. L., Brody M. J. ldquo;Immunological sympathectomy and CC14 hepatotoxicity”. Proc. Soc. Exp. Biol. Med. 1964; 116: 557–560
   PubMed Web of Science ®Google Scholar
• Larson R. E., Plaa G. L., Crews L. M. ldquo;The effect of spinal cord transection on carbon tetrachloride hepatotoxicity”. Toxicol. Appl. Pharmacol. 1964; 6: 154–162
   Web of Science ®Google Scholar
• Kurstak C., Cote M. G., Plass G. L. ldquo;Effect of hypothermia on carbon tetrachloride-induced changed in hepatic ultrastructure”. Toxicol. Appl. Pharmacol. 1973; 26: 14–28
   PubMed Web of Science ®Google Scholar
• Schwetz B. A., Plaa G. L. ldquo;Catecholamine potentiation of carbon tetrachloride-induced hepatotoxicity in mice”. Toxicol. Appl. Pharmacol. 1969; 14: 495–509
   PubMed Web of Science ®Google Scholar
• Iwai M., Saheki S., Ohta Y., Shimazu T. ldquo;Footshock stress accelerates carbon tetrachloride-induced liver injury in rats: Implication of the sympathetic nervous system”. Biomed. Res. 1986; 7: 145–154
   Web of Science ®Google Scholar
• Kulcsar-Gergely J., Kulcsar A. ldquo;The influence of a ganglion-blocking agent on experimental liver injury”. Toxicology 1973; 1: 125–130
   PubMedGoogle Scholar
• Wei E., Wong L. C. K., Hine C. H. ldquo;Potentiation of carbon tetrachloride hepatotoxicity by ethanol and cold”. Toxicol. Appl. Pharmacol. 1971; 18: 329–334
   PubMed Web of Science ®Google Scholar
• Roberts S. M., Harbison R. D., Seng J. E., James R. C. ldquo;Potentiation of carbon tetrachloride hepatotoxicity by phenylpropanolamine”. Toxicol. Appl. Pharmacol. 1991; 111: 175–188
   PubMed Web of Science ®Google Scholar
• Roberts S. M., Harbison R. D., James R. C. ldquo;Methamphetamine potentiation of carbon tetrachloride hepatotoxicity in mice”. J. Pharmacol. Exp. Ther. 1994; 271: 1051–1057
   PubMed Web of Science ®Google Scholar
• Roberts S. M., Harbison R. D., Westhouse R. A., James R. C. ldquo;Exacerbation of carbon tetrachloride-induced liver injury in the rat by methamphetamine”. Toxicol. Lett. 1995; 76: 77–83
   PubMed Web of Science ®Google Scholar
• Roberts S. M., Harbison R. D., James R. C. ldquo;Mechanistic studies on the potentiation of carbon tetrachloride hepatotoxicity by methamphetamine”. Toxicology 1995; 97: 49–57
   PubMed Web of Science ®Google Scholar
• Iwai M., Shimazu T. ldquo;Effects of ventromedial and lateral hypothalamic stimulation on chemically-induced liver injury in rats”. Life Sci. 1988; 42: 1833–1840
   PubMed Web of Science ®Google Scholar
• Zempel J. A., Dietz F. K., Traiger G. J. Effect of amphetamine, methamphetamine, and vasopressin on the hepatotoxicity of CCl4, CHBr3, and CHCL3. Pharmacologist 1983; 25: 169
   Google Scholar
• Strubelt O., Breining H. Influence of hypoxia on the hepatotoxic effects of carbon tetrachloride, paracetamol, allyl alcohol, bromobenzene, and thioacetamide. Toxicol. Lett. 1980; 6: 109–113
   PubMed Web of Science ®Google Scholar
• Shen E. S., Garry V. F., Anders M. W. ldquo;Effect of hypoxia on carbon tetrachloride hepatotoxicity”. Biochem. Pharmacol. 1982; 31: 3787–3793
   PubMed Web of Science ®Google Scholar
• Siegers C. P., Horn W., Younes M. ldquo;Effect of hypoxia on the metabolism and hepatotoxicity of carbon tetrachloride and vinylidene chloride in rats”. Acta Pharmacol. Toxicol. 1985; 56: 81–86
   PubMedGoogle Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. ldquo;Acetaminopohen-induced hepatic necrosis. IV. Protective role of glutathione”. J. Pharmacol. Exp. Ther. 1973; 187: 211–217
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. ldquo;Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo”. J. Pharmacol. Exp. Ther. 1973; 187: 195–202
   PubMed Web of Science ®Google Scholar
• Hinson J. A. ldquo;Biochemical toxicology of acetaminophen”. Rev. Biochem. Toxciol. 1980; 69: 279–290
   Google Scholar
• James R. C., Roberts S. M., Harbison R. D. The perturbation of hepatic glutathione by α2 adrenergic agonists. Fundam. Appl. Toxicol. 1983; 3: 303–308
   PubMedGoogle Scholar
• James R. C., Schieffer M. A., Roberts S. M., Harbison R. D. ldquo;Antagonism of cocaine-induced hepatotoxicity by the alpha adrenergic antagonists phentolamine and yohimbine”. J. Pharmcol. Exp. Ther. 1987; 242: 726–732
   PubMed Web of Science ®Google Scholar
• Estrela J. M., Gil F., Vila J. M., Vina J. α-Adrenergic modulation of glutathione metabolism in isolated rat hepatocytes. Am. J. Physiol. 1988; 255: E801–E805.
   PubMed Web of Science ®Google Scholar
• Harbison R. D., James R. C., Roberts S. M. ldquo;Hepatic glutahione suppression by the α-adrenoreceptor stimulating agents phenylephrine and clonidine”. Toxicology 1991; 69: 279–290
   PubMed Web of Science ®Google Scholar
• James R. C., Harbison R. D., Roberts S. M. ldquo;Phenylpropanolamine potentiation of acetaminophen-induced hepatotoxicity: Evidence for a glutathione-dependent mechanism”. Toxicol. Appl. Pharmacol. 1993; 118: 159–168
   PubMed Web of Science ®Google Scholar
• Mehta H., Murray B., Loiudice T. A. ldquo;Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride”. J. Clin. Gastroenterol. 1984; 6: 149–151
   PubMed Web of Science ®Google Scholar
• Goodman C. R. Hepatotoxicity due to methylphenidate hydrochloride. NY State J. Med. 1972; 72: 2339–2340
   PubMedGoogle Scholar
• Roberts S. M., Harbison R. D., Roth L., James R. C. ldquo;Methylphenidate-induced hepatotoxicity in mice and its potentiation by β-adrenergic agonist drugs”. Life Sci. 1994; 55: 269–281
   PubMed Web of Science ®Google Scholar
• Boelsterli U. A., Goeldin C. ldquo;Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites”. Toxicology 1991; 65: 351–360
   Web of Science ®Google Scholar
• Evans M. A., Harbison R. D. ldquo;Cocaine-induced hepatotoxicity in mice”. Toxicol. Appl. Pharmacol. 1978; 45: 739–754
   PubMed Web of Science ®Google Scholar
• Evans M. A. ldquo;Role of protein binding in cocaine-induced hepatic necrosis”. J. Pharmacol. Exp. Ther. 1983; 224: 73–79
   PubMed Web of Science ®Google Scholar
• Thompson M. L., Schuster L., Shaw K. ldquo;Cocaine-induced necrosis in mice”. Biochem. Pharmacol. 1979; 28: 2389–2395
   PubMed Web of Science ®Google Scholar
• Van Dyke C., Byck R. Cocaine and other stimulants, in Advances in Behavioral Biology, E. H. Ellinwood, M. M. Kelby. Plenum Press, New York 1978
   Google Scholar
• Chieuh C. C., Kopin I. J. ldquo;Centrally mediated release by cocaine of endogenous epinephrine from the sympathoadrenal medullary system of unanesthetized rats”. J. Pharmcal. Exp. Ther. 1978; 205: 148–154
   PubMed Web of Science ®Google Scholar
• Reid W. D., Christie B., Krishna G., Mitchell J. R., Moskowitz J., Brodie B. B. ldquo;Bromobenzene metabolism and hepatic necrosis”. Pharmacology 1971; 6: 41–55
   PubMed Web of Science ®Google Scholar
• Lau S. S., Monks T. J. ldquo;The contribution of bromobenzene to our current understanding of chemically-induced toxicities”. Life Sci. 1988; 42: 1259–1269
   PubMed Web of Science ®Google Scholar
• Monks T. J., Hinson J. A., Gillette J. R. Bromobenzene and p-bromophenol toxicity and covalent binding in vivo. Life Sci. 1982; 30: 841–848
   PubMed Web of Science ®Google Scholar
• Fisher R., Brendel K., Hanzlik R. P. Correlation of metabolism, covalent binding and toxicity for a series of bromobenzene derivatives using rat liver slices in vitro. Chem.–Biol. Interact. 1993; 88: 191–208
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Zampaglione N., Gillete J. R. Bromobenzene-induced liver necrosis: Protective role of glutahione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151–169
   PubMed Web of Science ®Google Scholar
• Thor H., Svensson S., Hartzell P., Orrenius S. Biotransformation of bromobenzene to reactive metabolites by isolated hepatocytes. Biological Reactive Intermediates, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, D. M. Witmer. Plenum, New York 1982; 287–298, II, Part A
   Google Scholar
• Smith C. V., Hughes H., Mitchell J. R. Free radicals in vivo covalent binding to lipids. Mol. Pharmacol. 1984; 26: 112–116
   PubMed Web of Science ®Google Scholar
• Slaughter D. E., Zheng J., Harriman S., Hanzlik R. P. ldquo;Identification of covalent adducts to protein sulfur nucleophiles by alkaline permethylation”. Anal. Biochem. 1993; 208: 288–295
   PubMed Web of Science ®Google Scholar
• Hanzlik R. P., Harriman S. P., Frauenhoff M. M. ldquo;Covalent binding of benzoquinone to reduced ribonuclease: Adduct structures and stoichiometry”. Chem. Res. Toxicol. 1994; 7: 177–184
   PubMed Web of Science ®Google Scholar
• Orrenius S., Mc Conkey D. J., Bellomo G., Nicotera P. Role of Ca2+ in toxic cell killing. Trends Pharmacol. Sci. 1989; 10: 281–285
   PubMed Web of Science ®Google Scholar
• Lamb R. G., Mc Cue S. B., Taylor D. R., Mc Guffin M. A. ldquo;The role of phospholipid metabolism in bromobenzene- and carbon tetrachloride-dependent hepatocyte injury”. Toxicol. Appl. Pharmacol. 1984; 75: 510–520
   PubMed Web of Science ®Google Scholar
• Kerger B. D., Gandy J., Bucci T. J., Roberts S. M., Harbison R. D., James R. C. Antagonism of bromobenzene-induced hepatotoxicity by the α-adrenergic blocking agents, phentolamine and idazoxan. Toxicol. Appl. Pharmacol. 1988; 95: 12–23
   PubMed Web of Science ®Google Scholar
• Kerger B. D., Roberts S. M., Hinson J. A., Gandy J., Harbison R. D., James R. C. Antagonism of bromobenzene-induced hepatotoxicity by phentolamine: Evidence for a metabolism-independent intervention. Toxicol. Appl. Pharmacol. 1988; 95: 24–31
   PubMed Web of Science ®Google Scholar
• Kerger B. D., Roberts S. M., Harbison R. D., James R. C. ldquo;Antagonism of bromobenzene-induced hepatotoxicity by the α-adrenoreceptor blocking agents phentolamine and idazoxan: Role of hypothermia”. Toxicol. Appl. Pharmacol. 1989; 97: 360–369
   PubMed Web of Science ®Google Scholar
• Harbison R. D., Gill J., Roberts S. M., De Mott R. P. Reevaluation of adrenoreceptor mediated hepatoprotection from bromobenzene. The Toxicologist 1996; 16: 1486, abstract
   Google Scholar
• Keck F. S., Wolf C., Foldenauer A., Zeller G., Kerner W., Pfeiffer E. F. ldquo;Hepatic sulfhydryl content under adrenergic stimulation in male rats”. Drug Res. 1991; 41: 6–9
   Web of Science ®Google Scholar
• Alvarez C., Blade C., Cartana J. α2-Adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats. Toxicol. Appl. Pharmacol. 1993; 121: 112–117
   PubMed Web of Science ®Google Scholar
• De Mott R. P., James R. C., Roberts S. M., Harbison R. D. Antagonism of bromobenzene-induced hepatotoxicity following delayed administration of phentolamine. The Toxicologist 1994; 14(1)699, abstract
   Google Scholar
• Mac Donald J. R., Gandolfi A. J., Sipes I. G. ldquo;Cysteamine modulation of galactosamine-induced hepatotoxicity”. Toxicol. Appl. Pharmacol. 1984; 73: 551–558
   PubMed Web of Science ®Google Scholar